9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma

Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma

Estimated reading time: < 1 min

Condition: Mesothelioma

Estimated Enrollment: 6

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Active, not recruiting

Study Results: No Results Available

Outcome Measures: number of patients who have a clinical benefit rate (CBR) (cohort 1),  maximum tolerated dose (MTD) (cohort 2),  ,

Interventions: pevonedistat, Pemetrexed and cisplatin

Phase:

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Intervention Model: Sequential Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date: October 2020

Completion Date: October 2020

Last  Posted Date: June 27, 2019

Location: Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

Website Link: https://ClinicalTrials.gov/show/NCT03319537

Was this article helpful?
Dislike 0